Related by context. All words. (Click for frequent words.) 71 Patient Enrollment 70 Achieves Primary Endpoint 70 Embolic Protection 70 Initiates Enrollment 69 Regeneron Pharma 69 Completes Patient Enrollment 68 Initiates Clinical Trial 68 Pivotal Clinical Trial 68 Initiates Clinical 68 Rheumatoid Arthritis Drug 68 MBRX 68 MultiCell Technologies 68 Sunesis Pharma 68 Phase 2a Trial 68 Quark Pharmaceuticals 68 Metabasis Therapeutics 68 Aegerion Pharmaceuticals 68 Cyclacel Pharmaceuticals 68 Files IND 68 Phase 2b Clinical Trial 68 Clinical Trial Data 68 DOV Pharmaceutical Inc. 68 Begins Dosing 68 Meets Primary Endpoint 67 ACADIA Pharmaceuticals 67 Vion Pharmaceuticals 67 Altus Pharmaceuticals 67 NDA Submission 67 GENR 67 Initiates Phase II 67 Receives CE Marking 67 PHRM 67 Tezampanel 66 Alvine Pharmaceuticals 66 XOMA XOMA 66 Milestone Payment 66 NLTX 66 Receive Milestone Payment 66 Drug Fails 66 Inspire Pharma 66 Cholesterol Lowering Drug 66 Milestone Payment From 66 Gets FDA Clearance 66 Myoblast 66 Halozyme Therapeutics 66 IND Filing 66 Systemic Delivery 66 Anika Therapeutics 66 Receives Orphan Drug Designation 66 Arno Therapeutics 66 Threshold Pharmaceuticals 66 Momenta Pharmaceuticals MNTA 66 Initiates Clinical Trials 66 Personalized Immunotherapy 66 Submits Response 66 Therapeutic Competitors Companies 66 Licenses Novel 66 Indevus Pharma 65 Drug Prevents 65 Idenix Pharma 65 Myrexis Inc. 65 Apricus Biosciences 65 Submits NDA 65 Ercole Biotech 65 R lenalidomide 65 Agios Pharmaceuticals 65 Announces Poster Presentations 65 CeNeRx BioPharma 65 Immunotherapeutic 65 Alexion Pharma 65 VIA Pharmaceuticals 65 Preclinical Study 65 FDA Approvals 65 Patients Treated With 65 TRACON Pharmaceuticals 65 Auxilium Pharma 65 VentiRx Pharmaceuticals 65 Shows Promise Against 65 Announces FDA Clearance 65 Presents Preclinical 65 Pivotal Study 65 Seattle Genetics SGEN 65 Platinum Chromium 65 Isis Pharma 65 Psoriasis Drug 65 Telik logo TELINTRA 65 Romiplostim 65 Pluristem Therapeutics 65 Sunesis Pharmaceuticals 65 CancerVax Corporation 65 Successfully Completes Phase 65 Lupus Drug 65 Ariad Pharma 65 LymphoStat B belimumab 65 Enzon Pharmaceuticals Inc 65 Initiate Clinical Trial 65 Accuray ARAY 65 ROSG 65 Bucindolol 65 Genaera Corporation 65 OSI Pharma 65 Microwave Ablation System 65 Migraine Drug 65 PROMUS R 65 ARYX 64 Phase 2b Trial 64 Quark Biotech 64 Drug Coated Stent 64 HDAC Inhibitor 64 Phase IIb Clinical Trial 64 Interferon Beta 64 OSIR 64 Accentia Biopharmaceuticals 64 Curon Medical 64 AVEO Pharmaceuticals 64 NRGN 64 BioLife Solutions 64 Angiotech Pharma 64 Phase III Pivotal 64 Taligen Therapeutics 64 Akesis Pharmaceuticals 64 proprietary radiolabeled monoclonal 64 Receives Milestone Payment 64 Cordex Pharma 64 Valera Pharmaceuticals 64 Diatos SA 64 BioSante Pharmaceuticals Announces 64 CYT# potent vascular disrupting 64 BXT # 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 AcryMed Incorporated 64 PRAECIS PHARMACEUTICALS INCORPORATED 64 NPS Pharma 64 Nasdaq EPCT 64 Inovio Pharmaceuticals 64 Hyperparathyroidism 64 OMRIX Biopharmaceuticals 64 Portola Pharmaceuticals 64 Alexza Pharma 64 Emphasys Medical 64 Aphton Corporation 64 Inc. OTCBB SPRX 64 Inhaled Insulin 64 Nasdaq SMTS develops manufactures 64 Anticancer Agent 64 Anti Tumor 64 Muraglitazar 64 TTHI 64 Adenosine Therapeutics 64 Trubion Pharmaceuticals TRBN 64 IG HCR ;) CO 64 Protalix BioTherapeutics 64 Arthritis Drug 64 Corautus Genetics Inc. 64 Demonstrates Significant 64 Initiates Phase III 64 Threshold Pharmaceuticals Inc. 64 KAI Pharmaceuticals 64 AcelRx Pharmaceuticals 64 Expanded Indication 64 PF # [002] 64 Nexeon MedSystems 64 Biomarker Study 64 Cardioxyl Pharmaceuticals 64 ESBATech AG 64 DOV Pharmaceutical 64 TKPHF 63 CureDM 63 Idenix Pharmaceuticals 63 EVIZON TM 63 MSCRAMM ® 63 CombinatoRx Incorporated 63 Idera Pharmaceuticals 63 Receives Approvable Letter 63 AMEX RGN 63 OTCBB ADMP 63 Phase III Trial 63 Emisphere Technologies 63 JAK2 Inhibitor 63 Mersana Therapeutics Inc. 63 RNVS 63 Somaxon Pharma 63 Ligand Pharma 63 Epiphany Biosciences 63 PDUFA Date 63 Amorcyte 63 LGND 63 Alnylam Nasdaq ALNY 63 Poniard Pharmaceuticals PARD 63 RDYN 63 TolerRx 63 Phase IIb Trial 63 InNexus Biotechnology 63 Ocrelizumab 63 Tasigna prolongs 63 pentadentate logo R 63 ImaRx Therapeutics 63 includes Dideco CarboMedics 63 Regenerative Cells 63 Submits IND 63 ThermoDox ® clinical 63 Nasdaq AVNC 63 ARCA biopharma 63 InfuSystem Holdings Inc. 63 Prism Pharmaceuticals 63 Cypher Sirolimus 63 VisEn Medical 63 ALN HPN 63 Phase Ib Clinical Trial 63 Antithrombin 63 Pivotal Phase III 63 Potelligent Technology 63 Optimer Pharma 63 Aurora Kinase 63 Pharmos Corporation 63 ATRA IV 63 Hana Biosciences 63 AFREZZA TM 63 NOVAVAX 63 H.B. Fuller 63 Micromet MITI 63 Volcano Therapeutics 63 miRagen Therapeutics 63 Ardea Biosciences 63 Myocet 63 Milestone Payments 63 t2cure GmbH 63 CardioTech International 63 Silodosin 63 BioMarin Pharma 63 Biomerix Corporation 63 MKC# MKC# PP 63 RECOTHROM R 63 CYP#A# CYP#D# 63 Nile Therapeutics 63 Ecallantide 63 Transcept Pharmaceuticals 63 Aegerion Pharmaceuticals Inc. 63 Clinical Trial Results 63 Oxis International 63 AMPLATZER R 63 Cyclooxygenase 2 63 David W. Gryska 63 Psivida 63 HuMax 63 Abbokinase 63 Generx TM 63 Nipent R 63 alpha#beta# integrin 63 By JAMAAL ABDUL 63 Present Preclinical Data 62 Corautus 62 Genome Therapeutics 62 Spectranetics SPNC 62 Brussels THR 62 GTOP 62 Conatus Pharmaceuticals 62 Mg Usa 62 UGNE 62 Diabetic Neuropathy 62 Diasome Pharmaceuticals 62 Corcept Therapeutics CORT 62 candidates Azedra TM 62 Resolvyx Pharmaceuticals 62 platform HDL Mimetic 62 Vicuron Pharmaceuticals 62 DARA BioSciences 62 EPIX Pharmaceuticals 62 Nasdaq ACHN 62 Recombinant Human 62 Array BioPharma ARRY 62 Nasdaq RXII 62 CyDex Pharmaceuticals 62 Novelos Therapeutics 62 Hsp# Inhibitor 62 IMRX 62 EntreMed Inc. 62 Cubist Pharma 62 Oncobionic 62 glucokinase activator 62 NASDAQ CYTX 62 Transdermal Delivery 62 Enzon Pharmaceuticals 62 please visit http:/www.atherogenics.com 62 Alnylam Pharmaceuticals Nasdaq ALNY 62 SagaX 62 Neose Technologies 62 Bioform Medical 62 Glufosfamide 62 Agenus 62 SinuNase ™ 62 Adventrx Pharmaceuticals 62 Cholestech Corporation 62 Biosite Incorporated 62 Adamis Pharmaceuticals 62 FoldRx Pharmaceuticals Inc. 62 Zelos Therapeutics 62 Ivivi Technologies 62 Vicriviroc 62 TM Everolimus Eluting 62 Drug Eluting Coronary Stent 62 Presents Preclinical Data 62 Liprotamase 62 NovaBay Pharmaceuticals 62 MSON 62 acetonide FA 62 Oncothyreon NASDAQ ONTY 62 Initiates Dosing 62 MelaFind R 62 Somaxon Pharmaceuticals 62 Antiangiogenic 62 STARFlex R 62 novel emulsion formulation 62 vapreotide acetate 62 DermTech International 62 Receptos 62 Investigational Compound 62 delivery polymer matrix 62 Inc Therapeutic Competitors 62 Reports Preclinical Data 62 DRRX 62 PANC 62 Angiox ® 62 Aerie Pharmaceuticals 62 Genotyping Test 62 GVAX ® 62 HuMax TAC 62 Northstar Neuroscience 62 Craig Tooman 62 Advanced Magnetics 62 Endologix Powerlink System 62 Ischemic 62 Eyetech Pharmaceuticals 62 Randomized Study 62 SciClone Pharma 62 Entremed 62 Vascugel 62 Announce License Agreement 62 FDA Approvable Letter 62 MorphoSys AG FSE MOR 62 initiated Phase 1b 62 IDIX 62 Naglazyme R 62 Prolor Biotech 62 Pegloticase 62 IL# PE#QQR 62 EnVivo Pharmaceuticals 62 targeted radiotherapeutic 62 Nasdaq CYTX 62 NASDAQ BSMD medical 62 Anadys Pharmaceuticals 62 NV1FGF 62 TRANSDUR ® 62 oncolytic virus therapies 62 Deforolimus 62 DUROS 62 R Saizen R 62 ProChon Biotech 62 Mylan Receives Approval 62 R sorafenib tablets 62 Vitaxin 62 Factor VIIa 62 Ridaforolimus 62 FLDM 62 NGSX 62 Javelin Pharmaceuticals 62 chronic thromboembolic pulmonary 62 Tesmilifene 62 Surgical Mesh 62 Syndax Pharmaceuticals Inc. 62 DP VPA 62 Regulus Therapeutics 62 Alnylam ALNY 62 Creabilis Therapeutics 62 Nereus Pharmaceuticals 62 Hybridon 62 TRBN 62 Rigel Pharmaceuticals 62 antisense inhibitors 62 Keryx Biopharmaceuticals KERX 62 NAVISTAR R 62 Inc. NASDAQ EVVV 62 LymphoStat B TM 62 FOLOTYN ® 62 ViroChem Pharma Inc. 62 Inc. OTCBB CYKN 62 gefitinib Iressa 62 BPAX 62 sunitinib Sutent 62 Predix Pharmaceuticals 62 Panacos Pharmaceuticals 62 Intravitreal 62 CRYO 62 personalized cellular immunotherapy 62 Zorbtive TM 62 Sunshine Biopharma 62 Refractory Hodgkin Lymphoma 62 Xanthus Pharmaceuticals Inc. 62 Osiris Therapeutics 62 Namenda Memantine HCl 62 XTNT 62 Nasdaq IDIX 62 SRDX 62 DYAX 62 FDA Accepts 62 BFRM 62 CardioVascular BioTherapeutics Inc. 61 Vaughn M. Kailian 61 Genelabs Technologies 61 Febuxostat 61 Drug Eluting Stent System 61 Targanta Therapeutics Corporation 61 ASX PGL 61 midstage clinical 61 Doripenem 61 TO AVOID PREGNANCY WHILE 61 Friedreich Ataxia FRDA 61 PRN FDA Approves 61 Encysive Pharma 61 Nasdaq PGNX 61 Gendux AB 61 Arqule 61 Sontra Medical Corporation 61 KAI Pharmaceuticals Inc. 61 Hoyoung Huh 61 Takeda Pharma 61 CRTX 61 Omacetaxine 61 Extracellular Matrix 61 ARQL 61 Hedgehog Pathway Inhibitor 61 Thalomid ® 61 NASDAQ ALXN 61 Immunogen IMGN 61 PROCRIT ® 61 Keryx Biopharmaceuticals 61 Optimer Pharmaceuticals Inc 61 TRANSDUR ™ 61 Inc. OTCBB BMSN 61 Hematological Malignancies 61 NASDAQ ENZN 61 Xcytrin R 61 peptidic compound 61 PSDV 61 ELGX 61 Theraputics 61 Aflibercept 61 NASDAQ OMER 61 Catalyst Biosciences 61 Hernia Repair 61 tramiprosate Alzhemed TM 61 Sangamo BioSciences 61 Panzem R 61 Dural Regeneration Matrix 61 Minimally Invasive Procedure 61 AstraZeneca Iressa 61 Vitrasert R 61 RECOTHROM ® 61 Bayhill Therapeutics 61 ARRY # 61 PLX STROKE targeting 61 Locked Nucleic Acid 61 please visit http:/www.sunesis.com 61 Nasdaq THLD 61 non nucleoside inhibitor 61 Amylin Pharma 61 MKC# MT 61 Myriad logo BRACAnalysis 61 Daclizumab 61 Auxilium Pharmaceuticals AUXL 61 FDA APPROVES 61 VentiRx 61 NASDAQ BIOD 61 Embolic Protection Device 61 Ceflatonin R 61 Bayer Onyx 61 HaptoGuard 61 IV Busulfex 61 Protein Polymer Technologies 61 OMRIX Biopharmaceuticals Inc. 61 Therapeutic Competitors Report 61 Kosan dependence 61 Nasdaq ACEL 61 Inhibitex INHX 61 Lung Rx 61 hypervascular tumors 61 AcuFocus 61 Ophthotech 61 Nasdaq OSIP 61 Progenics Pharmaceuticals 61 Gamunex C 61 Acute Decompensated Heart Failure 61 Regado Biosciences 61 Vidaza R 61 NSTK 61 ZEVALIN ® 61 IMMU 61 MicroMed Cardiovascular Inc. 61 Granulocyte Colony Stimulating Factor 61 ISTO Technologies 61 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 61 Aegera Therapeutics 61 Alseres Pharmaceuticals 61 developing ACAPODENE 61 Chronogen 61 LeMaitre Vascular 61 MEDW 61 Ascent Therapeutics 61 BCLI 61 XL# anticancer compounds 61 eResearchTechnology 61 BOSTON SCIENTIFIC 61 Epeius Biotechnologies Corporation 61 Announces Tentative Approval 61 Albugon 61 LEUKINE 61 Sopherion Therapeutics 61 Initiate Phase 61 Archexin 61 Mipomersen 61 Xoma Ltd 61 Nasdaq PARD 61 Tibotec BVBA 61 Medistem Laboratories 61 oral salmon calcitonin 61 Peregrine Pharma 61 Raven Biotechnologies 61 Alnylam Pharma 61 Saladax Biomedical 61 Bioabsorbable 61 Synta Pharma 61 Novel Protein 61 SOLX 61 Abviva Inc. 61 Nasdaq VNDA 61 SGXP 61 Erythropoietic therapies may 61 RhuDex 61 Cypress Bioscience CYPB 61 ARCA Biopharma 61 TESARO 61 Generic Version 61 TNGN 61 JAK Inhibitor 61 Nasdaq KOSN 61 VIVUS VVUS 61 visit http:/www.mannkindcorp.com 61 small molecule tyrosine 61 IMiDs ® compound 61 DVAX 61 Harbor BioSciences 61 Altair Therapeutics 61 Urocortin 2 61 Chemokine 61 Rexahn Pharmaceuticals 61 CD# CEA 61 Calibrant Biosystems 61 rasagiline tablets 61 PBTH 61 FivePrime Therapeutics 61 fusion enhancers 61 Nycomed GmbH 61 Receives Fast Track 61 CRXX 61 Medicis Pharmaceutical Corp 61 Launches Generic Version 61 attach auristatin 61 eResearchTechnology Inc. 61 cathepsin K inhibitor 61 Ziopharm 61 Inc. NASDAQ CBST 61 Acceleron Pharma 61 P#X# antagonist 61 NASDAQ HTWR 61 NASDAQ ENMD 61 SafeStitch Medical 61 Alimera Sciences Inc 61 GTC NASDAQ GTCB 61 Phase III Trials 61 EZEM 61 HepaLife TM 61 Thromboembolic 61 Regeneron Pharmaceuticals REGN 61 Questcor Pharma 61 novel VDA molecule 61 Kythera Biopharmaceuticals 61 Immunomedics Inc 61 Peripheral Arterial 60 Angiotensin Converting Enzyme 60 Trubion Pharmaceuticals 60 LeMaitre Vascular Inc. 60 Kinase Inhibitor 60 Bellus Health 60 Celldex Therapeutics NASDAQ CLDX 60 NASDAQ DIGE 60 Maxim Pharmaceuticals 60 Akebia Therapeutics 60 Boniva ibandronate 60 OTCBB CVBT 60 FlowCardia Inc. 60 Cepheid CPHD 60 TargeGen 60 NASDAQ RNAI 60 NEOL 60 Array BioPharma 60 VRUS 60 MEMY 60 non porcine pancreatic 60 Known hypersensitivity 60 molecular imaging radiopharmaceutical 60 HepaMate 60 NASDAQ ACOR 60 Intravascular 60 MNOV 60 initiated Phase Ib 60 oral prodrug 60 HCV RNA polymerase 60 Exploit collaboration 60 Nasdaq ACAD 60 KOSN 60 novel synthetic PEGylated 60 chimeric monoclonal antibody 60 Supernus Pharmaceuticals 60 Nasdaq NPSP 60 Adenoma 60 Migenix 60 OSUR 60 Cleviprex TM clevidipine 60 Severe Sepsis 60 Æterna Zentaris 60 Kiadis 60 liver resection surgeries 60 Jiangbo Pharmaceuticals 60 Therapeutic Competitors 60 Celladon 60 Non Invasive Treatment 60 Chemokine Therapeutics 60 BioMarin BMRN 60 NYSE Amex PTN 60 Depomed DEPO 60 Threshold Pharma 60 Metabolic Disease 60 FOXH 60 HeartMate R 60 Alseres Pharmaceuticals Inc. 60 Therapeutic Antibody 60 Integra LifeSciences IART 60 Isis Pharmaceuticals ISIS 60 Logical Therapeutics 60 SinuNase TM 60 PI3K/Akt pathway inhibitor 60 Generex Biotechnology 60 Anthony Giovinazzo 60 Trophos 60 Locked Nucleic Acid LNA 60 Receives SFDA Approval 60 Epix Pharmaceuticals 60 Contrast Agent 60 Alnara Pharmaceuticals 60 Addrenex Pharmaceuticals 60 OTCBB HXBM developer 60 QuantRx Biomedical Corporation 60 Cerimon 60 Through Glycoscience R 60 Trubion Pharma 60 SUTENT ® 60 THR beta agonist 60 BioDelivery Sciences 60 LifeCell Corporation 60 Ariad Pharmaceuticals 60 Afferent Pharmaceuticals 60 RNAi Therapeutics 60 ADP receptor antagonist 60 Freedom Meditech 60 PDE# inhibitors 60 Monopril 60 siRNA Delivery 60 Generx ® 60 XTENT 60 VertiFlex ® 60 Keryx Biopharma 60 evaluating tivozanib 60 Anti VEGF 60 Merrimack Pharmaceuticals 60 Tykerb lapatinib 60 www.cellgenesys.com 60 Praecis 60 THLD 60 Pervasis 60 Preclinical Data 60 Hormone Refractory Prostate Cancer 60 NYSE Amex PBTH 60 Cequent Pharmaceuticals 60 NASDAQ AEZS 60 OvaRex R 60 Candesartan 60 Amira Pharmaceuticals 60 RegeneRx Biopharmaceuticals 60 Prometheus Laboratories 60 agonistic human 60 Valeant Pharma 60 NASDAQ ABII 60 Roche OTC RHHBY 60 ONCY 60 ERYtech Pharma 60 AUXL 60 Squalamine 60 dyslipidemia hypertension diabetes 60 PRN EpiCept 60 DepoMed 60 Inc. NASDAQ ORXE 60 OTCBB NEOP 60 Regeneron Pharmaceuticals Inc 60 dextromethorphan quinidine 60 Adenosine A2A 60 successfully commercialize Iluvien 60 Allogeneic 60 OTCBB PYTO 60 NTMD 60 Salmedix 60 Biogen Idec Elan 60 Daxor 60 IlluminOss 60 Xelox 60 Patient Outcomes 60 Onyx Pharmaceuticals Inc 60 Amex KAL 60 ZIOPHARM Oncology 60 Dynepo TM 60 Xenazine ® 60 Levoleucovorin 60 DUSA Pharmaceuticals 60 Max Neeman International 60 PROLOR Biotech Inc. 60 Phusion Laboratories 60 MOGN 60 About Positron Positron 60 NASDAQ PARD 60 Taglich Brothers Initiates Coverage 60 Agendia BV 60 FluoroPharma 60 Aegerion 60 OncoGenex Pharmaceuticals Inc. 60 Dementia Related Psychosis 60 Alair Bronchial Thermoplasty System 60 Adult Stem Cell Therapy 60 Iloperidone 60 ProFibrix 60 Omeros Corporation 60 CELGENE 60 Hypotension 60 Xytis 60 rThrombin 60 Achillion Pharmaceuticals Inc 60 Syntonix Pharmaceuticals 60 ABII 60 Onconase 60 M# rationally 60 Array Biopharma 60 Frankfurt XMP 60 Combivir Kivexa 60 Achillion Pharmaceuticals Inc. 60 Antisense Pharma GmbH 60 customizable drug eluting 60 NOVC 60 sitaxsentan 60 Tryton Medical Inc. 60 developing ostarine selective 60 thalidomide Thalomid 60 NASDAQ VRTX 60 Two Upcoming Investor 60 phase III isavuconazole 60 SomatoKine 60 Symmetry Medical SMA 60 MAGE A3 ASCI 60 Novel Therapies 60 Degarelix 60 Corp. ADLR 60 LibiGel ® 60 Radient Pharma 60 Inc. Nasdaq MITI 60 PCRX 60 Shire plc SHPGY 60 Phase 1b clinical trials 60 EpiCept Corporation 60 Nasdaq RDEA 60 Bone Biologics 60 Biolimus A9 60 HCV polymerase 60 adenosine A2A 60 Carotid 60 Transition Therapeutics 60 Microvascular 60 DeveloGen 60 Bovie Medical 60 Prospective Randomized 60 Varespladib 60 Colaris Colaris AP 60 M.D. Ph.D. 60 AMEX TTP 60 Begins Clinical Trial 60 Othera Pharmaceuticals Inc. 60 Nektar Therapeutics NKTR 60 EnteroMedics proprietary neuroblocking technology 60 Nxstage Medical 60 BARRX Medical Inc. 60 developing Bicifadine serotonin 60 Genelabs Technologies Inc. 60 Gastrointestinal Liner 60 Autoimmune Disease 60 Tikvah Therapeutics 60 Transkaryotic Therapies TKTX 60 Absorbable 60 OTC BB PVCT 60 ANGN 60 OTCBB CHKT 60 Stent Thrombosis 60 Mg Uk 60 epoprostenol sodium 60 OVIT 60 OMNARIS Nasal Spray 60 investigational immunotherapy 60 Cytokinetics CYTK 60 NASDAQ CLDX 60 NASDAQ REGN 60 Orthovita VITA 60 OTCBB IMUC 60 Auxilium Pharmaceuticals 60 Xcellerated T Cells 60 Zemiva TM 60 Immunex Corporation 60 ENZN 60 Angiocept 60 Antigenics NASDAQ AGEN 60 Oxigene 60 Physio Control wholly owned 60 ISIS Pharmaceuticals 60 XYOTAX TM 60 rxRNA 60 Mesoblast Limited ASX MSB 60 Eraxis 60 PrevOnco 60 Anidulafungin 60 PDGI 60 anaphylactic reactions bronchospasm 60 Icagen ICGN 59 Targacept TRGT 59 Less Invasive 59 NASDAQ LGND 59 Guides FY# Update 59 QRxPharma Limited 59 Eurand NV EURX 59 BioMarin Pharmaceutical 59 OSTE 59 Vertex VRTX 59 Prestara 59 Refractory Angina 59 Neurocrine Biosciences NBIX 59 Kosan Biosciences Incorporated 59 Æterna Zentaris Inc. 59 BioSante Pharmaceuticals 59 Bovie Medical Corporation 59 Nasdaq ENMD 59 Orphan Status 59 FORMA Therapeutics 59 PXSL 59 KuDOS 59 Euthymics Bioscience Inc. 59 PEGylated anti 59 orally administered inhibitor 59 Clinical Study Shows 59 vinorelbine tartrate 59 telomerase therapeutic 59 OTCBB UGNE http:/www.unigene.com 59 lexidronam injection 59 NTII 59 QuatRx Pharmaceuticals 59 Spirus Medical 59 Romidepsin 59 Zentaris GmbH 59 Enzon Pharmaceuticals ENZN 59 Atypical Hemolytic Uremic Syndrome 59 Adamis Laboratories 59 Serostim ® 59 OTCBB INHI OTCBB INHIW 59 ® lenalidomide 59 Neogenix Oncology 59 Ambit Biosciences 59 Selective Electrochemical Tumor Ablation 59 Revotar 59 PDL BioPharma Announces 59 Airmedia Group Inc 59 Synta Pharmaceuticals SNTA 59 AMEX RNN 59 HepaLife Technologies Inc. 59 Vanda Pharma 59 SYN# 59 XTL Biopharmaceuticals Ltd. 59 Successfully Treats 59 Pyridorin 59 adenosine injection 59 NASDAQ EMIS 59 CYTR 59 Parathyroid hormone 59 Bioresorbable 59 hyaluronidase enzyme 59 Multidetector CT 59 Biosante Pharmaceuticals 59 Obtains Exclusive License 59 pan HDAC inhibitor 59 Wellstat 59 Immunomedics IMMU 59 EXPAREL TM 59 TSRX 59 Cethrin R 59 Celladon Corporation 59 J Am Coll 59 OTCBB HPLF 59 Adeona Pharmaceuticals 59 vitro pharmacology 59 biologic antibody 59 ThermoDox R 59 MAKO Surgical 59 ONI BioPharma Inc. 59 ISTA Pharmaceuticals 59 ImmunoCellular Therapeutics 59 Exherin 59 Takeda Kyowa Hakko Kirin 59 VNS Therapy TM 59 Nasdaq DVAX 59 Alexion Pharmaceuticals ALXN 59 NEXM 59 Nasdaq REGN 59 Ocular Therapeutix 59 selective modulator 59 Fovea Pharmaceuticals 59 fibrin deposition 59 AngioScore 59 Dr. Ayalew Tefferi 59 TOPIGEN Pharmaceuticals Inc. 59 www.vivus.com 59 NasdaqGM NTEC today 59 Pharmacopeia PCOP 59 Nasdaq LXRX 59 Cyclacel Pharma 59 phase IIb trial 59 ExonHit Therapeutics SA 59 MRNA 59 Thiazolidinediones 59 BioGeneriX 59 Teikoku Pharma USA 59 Nasdaq AGEN 59 CoTherix Inc. 59 Implantable Device 59 Dasatinib 59 QLTI 59 HQK 59 NOVN 59 NASDAQ ONXX 59 ONYX Pharmaceuticals 59 markets HP Acthar 59 Ception Therapeutics 59 Daxor Corporation 59 eResearch Technology 59 Announce Collaboration Agreement 59 octreotide acetate 59 Electro Optical Sciences 59 Epratuzumab 59 Foxhollow Technologies 59 Temsirolimus 59 Phase #b/#a clinical 59 INTEGRILIN 59 BNVI 59 Bioheart Inc. 59 Pirfenidone 59 Alethia Biotherapeutics 59 sargramostim 59 Brimonidine 59 Patent Lawsuit Against 59 Pervasis Therapeutics Inc. 59 Dosa suffers 59 PPD Nasdaq PPDI 59 InfaCare Pharmaceutical Corporation 59 AERx R 59 OPXA 59 Genetronics 59 IMC #B 59 Exelixis compounds 59 Nasdaq CADX 59 Advancis Pharmaceutical Corporation 59 Wellstat Therapeutics 59 Spectrum Pharmaceuticals SPPI 59 Implantable Defibrillators 59 Cara Therapeutics 59 SCRX 59 AviaraDx 59 Intraop Medical Corporation 59 Osmetech plc 59 endoluminal stent graft